Similar articles for PMID: 29198914

Year	Number of Results
2004	2
2008	2
2009	1
2010	1
2012	1
2013	4
2014	3
2015	12
2016	11
2017	17
2018	11
2019	6
2020	2
2021	2
2022	1
2023	2

1

Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.

Cosset É, Ilmjärv S, Dutoit V, Elliott K, von Schalscha T, Camargo MF, Reiss A, Moroishi T, Seguin L, Gomez G, Moo JS, Preynat-Seauve O, Krause KH, Chneiweiss H, Sarkaria JN, Guan KL, Dietrich PY, Weis SM, Mischel PS, Cheresh DA. Cosset É, et al. Cancer Cell. 2017 Dec 11;32(6):856-868.e5. doi: 10.1016/j.ccell.2017.10.016. Epub 2017 Nov 30. Cancer Cell. 2017. PMID: 29198914 Free PMC article.

2

Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma.

Zhang L, Shan X, Meng X, Gu T, Guo L, An X, Jiang Q, Ge H, Ning X. Zhang L, et al. Mol Pharm. 2019 Sep 3;16(9):3977-3984. doi: 10.1021/acs.molpharmaceut.9b00602. Epub 2019 Jul 29. Mol Pharm. 2019. PMID: 31306580

3

A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.

Libby CJ, Gc S, Benavides GA, Fisher JL, Williford SE, Zhang S, Tran AN, Gordon ER, Jones AB, Tuy K, Flavahan W, Gordillo J, Long A, Cooper SJ, Lasseigne BN, Augelli-Szafran CE, Darley-Usmar V, Hjelmeland AB. Libby CJ, et al. Cell Adh Migr. 2021 Dec;15(1):101-115. doi: 10.1080/19336918.2021.1903684. Cell Adh Migr. 2021. PMID: 33843470 Free PMC article.

4

Glut3 Addiction: A Druggable Vulnerability in Glioblastoma.

Bunda S, Zadeh G, Aldape KD. Bunda S, et al. Cancer Cell. 2017 Dec 11;32(6):726-727. doi: 10.1016/j.ccell.2017.11.017. Cancer Cell. 2017. PMID: 29232550 Free article.

5

Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.

Luchman HA, Stechishin OD, Nguyen SA, Lun XQ, Cairncross JG, Weiss S. Luchman HA, et al. Clin Cancer Res. 2014 Nov 15;20(22):5756-67. doi: 10.1158/1078-0432.CCR-13-3389. Epub 2014 Oct 14. Clin Cancer Res. 2014. PMID: 25316808

6

miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation.

Kwak S, Park SH, Kim SH, Sung GJ, Song JH, Jeong JH, Kim H, Ha CH, Kim SW, Choi KC. Kwak S, et al. J Exp Clin Cancer Res. 2022 Mar 8;41(1):87. doi: 10.1186/s13046-022-02305-5. J Exp Clin Cancer Res. 2022. PMID: 35260183 Free PMC article.

7

Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.

Stangeland B, Mughal AA, Grieg Z, Sandberg CJ, Joel M, Nygård S, Meling T, Murrell W, Vik Mo EO, Langmoen IA. Stangeland B, et al. Oncotarget. 2015 Sep 22;6(28):26192-215. doi: 10.18632/oncotarget.4613. Oncotarget. 2015. PMID: 26295306 Free PMC article.

8

miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.

Li Y, Liu Y, Ren J, Deng S, Yi G, Guo M, Shu S, Zhao L, Peng Y, Qi S. Li Y, et al. J Neurooncol. 2018 Jul;138(3):499-508. doi: 10.1007/s11060-018-2835-3. Epub 2018 Jun 6. J Neurooncol. 2018. PMID: 29876787

9

EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.

Liu Z, Han L, Dong Y, Tan Y, Li Y, Zhao M, Xie H, Ju H, Wang H, Zhao Y, Zheng Q, Wang Q, Su J, Fang C, Fu S, Jiang T, Liu J, Li X, Kang C, Ren H. Liu Z, et al. Oncotarget. 2016 Jan 26;7(4):4680-94. doi: 10.18632/oncotarget.6730. Oncotarget. 2016. PMID: 26717039 Free PMC article.

10

Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.

Franovic A, Elliott KC, Seguin L, Camargo MF, Weis SM, Cheresh DA. Franovic A, et al. Cancer Res. 2015 Nov 1;75(21):4466-73. doi: 10.1158/0008-5472.CAN-15-0988. Epub 2015 Aug 21. Cancer Res. 2015. PMID: 26297735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed